Acta Ortopédica Mexicana

Farfalli G, Albergo JI, Rodríguez M, Ayerza M, Muscolo L, Aponte-Tinao LA
Survival and complications analysis of 97 patients with bone metastases treated surgically
Acta Ortop Mex 2013; 27 (6)

Language: Espańol
References: 19
Page: 371-374
PDF: 177.96 Kb.

[Fulltext - PDF]

ABSTRACT

Background: The purpose of this paper is to assess the survival and the different factors predisposing to increased local and overall complications in a group of patients treated surgically for bone metastases. Material and methods: A total of 97 patients were included in our study, 45 females and 52 males. Mean age was 59 years (range 22-81) and the mean follow-up was 23 months (range 3-76). Were performed 104 surgical interventions. Patient survival was estimated with the Kaplan-Meier method. Complications, recurrences and the most significant factors were analyzed. Results: Overall patient survival was 73% at one year, 47% at 2 years, and 6% at 5 years. Patient survival was greater in patients with a histologic diagnosis of metastatic renal cancer (p › 0.05) and a higher incidence of local relapses (p › 0.05). Intralesional surgery significantly affected the relapses. Conclusions: Patients with metastatic renal cancer had the greatest survival rate. However, they were associated with a higher rate of local relapses and postoperative failure.


Key words: bone, metastasis, complications, kidney neoplasms.


REFERENCES

  1. 1.Fauci A, Braunwald E, Kasper D, et al: Principios de Medicina Interna. 17a edición. Harrison; 2008.

  2. 2.Durr HR, Müller PE, Lenz T, et al: Surgical treatment of bone metastases in patients with breast cancer. Clin Orthop Relat Res. 2002; (396): 191-6.

  3. Schwartz HS: Orthopaedic knowledge update. Musculoskeletal tumors II. American Academy of Orthopaedic Surgery; 2007.

  4. 4.Lin PP, Mirza AN, Lewis VO, et al: Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007; 89(8): 1794-801.

  5. 5.Nussbaum H, Allen B, Kagan AR, et al: Management of bone metastasis-multidisciplinary approach. Semin Oncol. 1977; 4(1): 93-7.

  6. 6.Fottner A, Szalantzy M, Wirthmann L, et al: Bone metastases from renal cell carcinoma: patient survival after surgical treatment. Musculoskeletal Disorders. 2010; 11: 145.

  7. 7.Penel N, Hollebecque A, Maynou C, et al: Development of a score that predicts survival among patients with bone metastasis revealing solid tumor. Support Care Cancer. 2008; 16: 1089-93.

  8. 8.Roland H, Müller P, Lenz T, Baur A: Surgical treatment of bone metastases in patients with breast cancer. Clin Orthop Rel Res. 2002, 396; 191-6.

  9. 9.Wedin R, Bauer H, Rutqvist L: Surgical Treatment for Skeletal Breast Cancer Metastases. Cancer. 2001; 92 (2), 257-62.

  10. 10.Althausen P, Althausen A, Jennings LC, Mankin HJ: Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer. 1997; 80: 1103-9.

  11. 11.Nilsson J, Gustafson P: Surgery for metastatic lesions of the femur: Good outcome after 245 operations in 216 patients. Injury. 2008; 39(4): 404-10.

  12. 12.Sarahrudi K, Greitbauer M, Platzer P, et al: Surgical treatment of metastatic fractures of the femur: a retrospective analysis of 142 patients. J Trauma. 2009; 66(4): 1158-63.

  13. 13.Greene FL, Page DL, Fleming ID, et al: AJCC Cancer staging manual. 6th Edition. New York: Springer; 2002: 232-5.

  14. 14.Ficarra V, Novara G, Galfano A, et al: The stage, size, grade and necrosis’ score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma. BJU Int. 2009; 103(2): 165-70.

  15. 15.Fottner A, Szalantzy M, Wirthmann L, et al: Bone metastases from renal cell carcinoma: patient survival after surgical treatment. Musculoskeletal Disorders. 2010; 11: 145.

  16. 16.Frank I, Blute ML, Cheville JC, Lohse CM, et al: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002; 168(6): 2395-400.

  17. 17.Mirels H: Metastatic Disease in Long Bones: A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989; (249): 256-63.

  18. 18.Patard JJ, Kim HL, Lam JS, et al: Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004; 22(16): 3316-22.

  19. 19.Tokuhashi Y, Matsuzaki H, Toriyama, et al: Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine. 1990; 15: 1110-3.